Pancreatic Cancer Research

Clinical trialNACompleted

Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

IIT2020-13-GRESHAM-ELLY: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Outcome
Finished, no results posted
Phase
NA
Status
Completed
Study type
Interventional
Start
2 December 2020
Expected end
17 May 2024
Enrollment
38 participants
Sites
1
Primary outcomes
Absolute change in patient-reported anxiety scores at Day 30 compared with baseline.
Sponsor
Other
Results posted
No
Last update
21 May 2024

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.